STN: BL 125703
Proper Name: brexucabtagene autoleucel
Manufacturer: Kite Pharma, Inc.
- For the treatment of adult patients with relapsed/refractory mantle cell lymphoma (r/r MCL).
- Package Insert - TECARTUS
- Demographic Subgroup Information - TECARTUS (brexucabtagene autoleucel)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.